Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?

M Michikawa - Journal of neuroscience research, 2003 - Wiley Online Library
Cholesterol is an essential component of membranes for maintaining their structure and
functions. The discovery that possession of apolipoprotein E (apoE), allele ϵ4 is a strong …

Alzheimer's disease and cholesterol: the fat connection

L Canevari, JB Clark - Neurochemical research, 2007 - Springer
Since the discovery of the significance of the cholesterol-carrying apolipoprotein E and
cholesterolaemia as major risk factors for Alzheimer's Disease (AD) there has been a …

Alzheimer's disease: the cholesterol connection

L Puglielli, RE Tanzi, DM Kovacs - Nature neuroscience, 2003 - nature.com
A hallmark of all forms of Alzheimer's disease (AD) is an abnormal accumulation of the β-
amyloid protein (Aβ) in specific brain regions. Both the generation and clearance of Aβ are …

Cholesterol and Alzheimer's disease: is there a link?

M Simons, P Keller, J Dichgans, JB Schulz - Neurology, 2001 - AAN Enterprises
Article abstract—The Aβ-amyloid peptide (Aβ), the main component of amyloid plaques, is
derived by proteolytic cleavage from the amyloid precursor protein (APP). Epidemiologic …

Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders

S Yasamineh, FJ Mehrabani, E Derafsh… - Molecular …, 2023 - Springer
Cholesterol is an essential component of mammalian cell membranes and a precursor for
crucial signaling molecules. The brain contains the highest level of cholesterol in the body …

Lipid metabolism in Alzheimer's and Parkinson's disease

Q Xu, Y Huang - Clinical Lipidology and Metabolic Disorders, 2006 - search.proquest.com
Lipids are an essential component of cellular bilayer membranes and the major energy
reserve in cells and tissues; lipid homeostasis is crucial for normal cell morphology, integrity …

Brain lipids in the pathophysiology and treatment of Alzheimer's disease

M Torres, X Busquets, PV Escribá - Update on Dementia, 2016 - books.google.com
Alzheimer's disease (AD) is a neurodegenerative disorder that causes severe and
progressive cognitive impairment. The discovery of specific mutations related to AD …

[HTML][HTML] Plasma lipids as biomarkers for Alzheimer's disease: a systematic review

M Agarwal, S Khan - Cureus, 2020 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is caused by several risk factors leading to dementia. It's diagnosis
usually depends on clinical presentation and certain biomarkers in the cerebrospinal fluid …

Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin

LU Fen, LI Xu, A Suo, J Zhang - Chinese medical journal, 2010 - journals.lww.com
Background Alzheimer's disease (AD) is a neurodegenerative disorder and the leading
cause of dementia in the elderly. The two hallmark lesions in AD brain are deposition of …

[HTML][HTML] Cholesterol and neuronal susceptibility to beta-amyloid toxicity

AM Nicholson, A Ferreira - Cognitive sciences, 2010 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a devastating neurocognitive disorder rapidly growing across
the elderly population. Although few cases arise due to genetic mutations, sporadic AD is …